Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy or bethlem myopathy

摘要

The present invention relates to the use of a nonimmunosuppressive cyclosporin A derivative for reducing mitochondrial dysfunction and the rate of apoptosis of muscle cells of patients diagnosed with Ullrich congenital muscular dystrophy or Bethlem myopathy.